QuoteMedia (QMCI) – Setting The Table For A Strong 2021

Monday, February 22, 2021

QuoteMedia (QMCI)
Setting The Table For A Strong 2021

QuoteMedia, based in Fountain Hills, Arizona, provides cloud-based financial data, market news feeds, and financial software solutions.  Its customers include financial service companies, online brokerages, clearing firms, banks, media portals, public corporations and individual investors.  The company provides a single source solution providing products such as streaming quotes, charting, historical data, technical analysis, news and research.  Information can customized and provided to multiple platforms including terminals and mobile devices.

Michael Kupinski, Director of Research, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Prospect of landing a big fish improves. We believe that the recently added new product feature sets and sourcing its own data should allow the company to compete for larger clients, more terminals, more usage. This provides the prospect for an acceleration in revenue growth to strong double digits growth, which would be expected for a company of this size, with improving margins.

    Q4 preview.  Q4 is likely to have a hangover from Covid related noise, including the prospect for higher bad debt expenses and expense accruals. As such, the improving revenue and cash flow trends that we originally thought would become evident may be masked by non recurring items. We are lowering our Q4 revenue estimate from $3.475 million to $3.275 million and our cash flow (adj. EBITDA) estimate …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Release – Comtech Telecommunications (CMTL) – Awarded Contract for 21.5m Radome from Commercial Space Company


Comtech Telecommunications Corp. Awarded Contract for 21.5m Radome from Commercial Space Company

 

MELVILLE, N.Y.–(BUSINESS WIRE)–Feb. 22, 2021– February 22, 2021– Comtech Telecommunications Corp. (NASDAQ: CMTL) announced today, that during its second quarter of fiscal year 2021, its Mission-Critical Technologies group’s Space & Component Technology Division, which is part of Comtech’s Government Solutions segment, was awarded a follow-on order from a multinational infrastructure support company for a 21.5m radome.

“Based on our success with this customer on the first radome we supplied, we are quite pleased that we were able to secure a follow-on order, providing our customer with the product and service they require for their satellite ground system and radar project,” said Fred Kornberg, Chairman of the Board and Chief Executive Officer of Comtech Telecommunications Corp.

For over 40 years, Comtech’s Space & Component Technology (“SCT”) division, located in Cypress, California, has specialized in the supply of high reliability microelectronics, supplying EEE parts for use in satellite, launch vehicle and manned space applications. Combining longstanding resources in Cypress, with new locations in Plano, Texas and Hampshire, United Kingdom, SCT also provides services encompassing all aspects of ground station life cycle management to include requirements definition and analysis, design, development and integration of turnkey systems from antenna to data processing, civil works and construction, station installation and verification, operations and maintenance, and decommissioning at end of life. A full line of satellite tracking antennas from 30cm to 13m, as well as RF feeds, radomes and carbon fiber reflectors, all for LEO, MEO and GEO orbits, are also supplied to customers worldwide. For more information, visit www.comtechspace.com.

The Mission-Critical Technologies group is focused on ensuring its customers are able to successfully carry out their mission, whether that be communicating in an austere environment on land or at sea, launching or tracking a satellite, or protecting the cyber security posture of their network.

Comtech Telecommunications Corp. designs, develops, produces, and markets innovative products, systems and services for advanced communications solutions. The Company sells products to a diverse customer base in the global commercial and government communications markets.

Certain information in this press release contains statements that are forward-looking in nature and involve certain significant risks and uncertainties. Actual results could differ materially from such forward-looking information. The Company’s Securities and Exchange Commission filings identify many such risks and uncertainties. Any forward-looking information in this press release is qualified in its entirety by the risks and uncertainties described in such Securities and Exchange Commission filings.

Media Contact:
Michael D. Porcelain, President and Chief Operating Officer
631-962-7000

info@comtechtel.com

Source: Comtech Telecommunications Corp.

QuickChek – February 22, 2021



Midwest Energy Emissions Corp. will convert outstanding principal into shares of the Company’s common stock

The Company will convert a total of $860,000 of outstanding principal into shares of the Company’s common stock at the Note’s conversion price of $0.50 per share.

News and Market Data on Midwest Energy Emissions


Watch recent presentation from NobleCon17



Gevo and Scandinavian Airlines System Amend $100 Million Fuel Agreement

Gevo, Inc. and Scandinavian Airlines System have signed an amendment to increase SAS’s minimum purchase obligation to purchase sustainable aviation fuel to 5,000,000 gallons per year.

Research, News and Market Data on Gevo


Watch recent presentation from NobleCon17



Comtech Telecommunications Awarded Contract for 21.5m Radome

Comtech Telecommunications announced that its Space & Component Technology Division was awarded a Q2 2021 follow-on order from a multinational infrastructure support company for a 21.5m radome.

Research, News and Market Data on Comtech


Watch recent presentation from NobleCon17

Stay up to date. Follow us:

           


Stay up to date. Follow us:

Release – Gevo (GEVO) – Gevo and Scandinavian Airlines System Amend $100 Million Fuel Agreement


Gevo and Scandinavian Airlines System Amend Agreement to Increase Off-Take of Sustainable Aviation Fuel, valued at over $100 Million

 

ENGLEWOOD, Colo., Feb. 22, 2021 (GLOBE NEWSWIRE) — Gevo, Inc. (NASDAQ: GEVO), announced today that it and Scandinavian Airlines System (“SAS”) have signed an amendment to increase SAS’s minimum purchase obligation to purchase sustainable aviation fuel (“SAF”) to 5,000,000 gallons per year. Gevo and SAS signed the original fuel sales agreement in October 2019 (the “Fuel Sales Agreement”).

With the finalization of this this amendment to the Fuel Sales Agreement (the “Amendment”), Gevo expects to supply SAS with SAF beginning in 2024 from Gevo’s Net-Zero 2 Project for use and distribution in low carbon fuel regions of the United States. The value of the Fuel Sales Agreement, as amended, is estimated at over $100 million over the entire term of the agreement inclusive of the related SAF and environmental credits.

“With this amendment, SAS has significantly increased the amount of SAF that it is willing to purchase from Gevo. This amendment is evidence of the strong and growing demand for Gevo’s renewable hydrocarbon products. We expect to ink additional offtake agreements later this year,” said Patrick R. Gruber, Chief Executive Officer of Gevo. “SAS have a vision and plan that they are executing, even in spite of the global pandemic. This additional volume will help Gevo grow its business and hopefully accelerate making real Gevo’s Net-Zero 2 plant,” added Mr. Gruber.

“SAS has an ambitious goal in reducing its’ absolute climate affecting emissions by 25 percent from 2005 levels by 2025. This increase of Gevo SAF will help us to reach at least 20% of the SAF needed to reach our emission reductions goal. SAS chooses partners like Gevo that have the vision and ambition to support the aviation industry’s transition to net zero emission,” says Lars Andersen Resare, Head of Sustainability, SAS.

Beyond Net-Zero 1

Gevo has introduced the concept of Net Zero Projects. Announced in early 2021, these production facilities are being designed to produce energy-dense liquid hydrocarbons using renewable energy and Gevo’s proprietary technology. The first Net-Zero project, Net-Zero 1, is expected to be built in Lake Preston, South Dakota.

The Net-Zero Projects are being designed to produce liquid hydrocarbons in the form of sustainable aviation fuel and renewable gasoline. These fuels, when used for transportation, should have a net-zero greenhouse-gas footprint as measured across the entire lifecycle, based on the Argonne National Laboratory’s GREET model.

Gevo expects that each Net-Zero Project will have the capability to produce approximately 45MGPY of liquid hydrocarbons (jet fuel and renewable gasoline) and are also expected to produce at least 350,000,000 lbs/yr of high protein animal feed. To reduce and eliminate the fossil fuel resources used in the production facilities, each Net Zero Project is expected to have an anaerobic digestion wastewater treatment plant that is capable of generating enough biogas to run the plant and supply a combined heat and power unit, capable of meeting approximately 30% of the plant’s electricity needs. The remaining 70% of electricity to run the plant is expected to come from wind power. Net-Zero 1 may also obtain renewable natural gas (“RNG”) using manure from dairy or beef cows. These efforts should make this Net-Zero 1 self-sufficient and help ensure it will be off a fossil-based grid. Gevo also believes in transparency and is setting up sustainability tracking methods to work alongside our farmers.

The Fuel Sales Agreement, as amended, is subject to certain conditions precedent. A copy of the Fuel Sales Agreement and the Amendment have been filed with the U.S. Securities and Exchange Commission on Form 8-K.

About Gevo

Gevo’s mission is to transform renewable energy and carbon into energy-dense liquid hydrocarbons. These liquid hydrocarbons can be used for drop-in transportation fuels such as gasoline, jet fuel, and diesel fuel, that have the potential to yield net-zero greenhouse gas emissions when measured across the full lifecycle of the products. Gevo uses low-carbon renewable resource-based carbohydrates as raw materials from residues and slurries, and is in an advanced state of developing renewable electricity and renewable natural gas for use in production processes, resulting in low-carbon fuels with substantially reduced carbon intensity (the level of greenhouse gas emissions compared to standard petroleum fossil-based fuels across their lifecycle) and GHG scores. Gevo’s products perform as well or better than traditional fossil-based fuels in infrastructure and engines, but with substantially reduced greenhouse gas emissions. In addition to addressing the problems of fuels, Gevo’s technology also enables certain plastics, such as polyester, to be made with more sustainable ingredients. Gevo’s ability to penetrate the growing low-carbon fuels market depends on the price of oil and the value of abating carbon emissions that would otherwise increase greenhouse gas emissions. Gevo believes that its proven and patented technology, which enables the use of a variety of low-carbon sustainable feedstocks to produce price-competitive low carbon products such as gasoline components, jet fuel, and diesel fuel, yields the potential to generate project and corporate returns that justify the build-out of a multi-billion-dollar business.

Learn more at Gevo’s website: www.gevo.com

About SAS

SAS, Scandinavia’s leading airline, with main hubs in Copenhagen, Oslo and Stockholm, flies to destinations in Europe, USA and Asia. Spurred by a Scandinavian heritage and sustainability values, SAS aims to be the global leader in sustainable aviation. We will reduce total carbon emissions by 25 percent by 2025, by using more sustainable aviation fuel and our modern fleet with fuel-efficient aircraft. In addition to flight operations, SAS offers ground handling services, technical maintenance and air cargo services. SAS is a founding member of the Star Alliance™, and together with its partner airlines offers a wide network worldwide.

Learn more at https://www.sasgroup.net

Forward-Looking Statements

Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to a variety of matters, including, without limitation, statements related to the Agreement and the Amendment, Gevo’s SAF, Gevo’s ability to produce the SAF, Gevo’s ability to realize revenue from the Agreement and Amendment, Gevo’s ability to enter into additional offtake agreements for its products, Gevo’s Net-Zero Projects, including Net-Zero 2, Gevo’s ability to produce products that have a “net-zero” greenhouse gas footprint, Gevo’s plans and strategy, the NW Iowa Project, Gevo’s ability to finance its projects, and other statements that are not purely statements of historical fact. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of the management of Gevo and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Gevo undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Gevo believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Gevo in general, see the risk disclosures in the Annual Report on Form 10-K of Gevo for the year ended December 31, 2019, and in subsequent reports on Forms 10-Q and 8-K and other filings made with the U.S. Securities and Exchange Commission by Gevo.

Investor and Media Contact
IR@gevo.com

+1 720-647-9605

SOURCE: Gevo

Kelly Services Inc. (KELYA) – Raising to Outperform on Positive Trends Favorable Risk Reward

Monday, February 22, 2021

Kelly Services Inc. (KELYA)
Raising to Outperform on Positive Trends, Favorable Risk/Reward

Kelly Services Inc is a provider of workforce solutions and consulting and staffing services. The company’s operations are divided into three business segments namely Americas Staffing, Global Talent Solutions (“GTS”) and International Staffing. It provides staffing solutions through its branch networks in Americas and International operations and also provides a suite of innovative talent fulfilment and outcome-based solutions through GTS segment. Americas Staffing generates maximum revenue from its operations.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    4Qtr Results. Kelly reported revenue of $1.24 billion in 4Q20, down 7.2% y-o-y. EPS was $0.59, and adjusted EPS was $0.41, compared to $0.43 and $0.71, respectively. Note, 4Q20 consisted of 53 weeks compared to 52 in 4Q19. We had forecast revenue of $1.15 billion and EPS of $0.28 while consensus called for revenue of $1.14B and EPS of $0.27.

    Improving Trends — 1.  While COVID continues to impact, particularly the Education market, Kelly saw positive trends over the quarter with each of Kelly’s five operating segments reporting sequential revenue improvement during the quarter. The OCG segment actually reported y-o-y growth in revenue. We believe Kelly is well positioned to benefit from improving economic trends …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Managing Investment Portfolio Risk

 


Two Ways High Performing Investment Portfolios Guard Against Losses

 

Are stocks overbought, or does the bull market have more to run? Sound arguments can be made for either side.

On the side that forecasts more stock market gains, they may point to earnings expectations. This makes sense since fewer pandemic-related restrictions are now leading to more business activity. Activity means earnings increases which normally equates to the stock market rising. On the bearish side, those that think the market is pricey and too risky may argue that interest rates have begun to move up from their historic lows. Higher rates add to the cost of doing business and serve to reduce consumer purchases. Additionally, stocks are an alternative for income investors that have left the bond market in hopes of a higher yield. As higher bond yields return, they may shed their stock market positions and return to the fixed income market.

Both bullish arguments and bearish positions have merit. This leaves investors with the decision to either leave a still booming stock market and possibly miss out on returns in exchange for near-zero interest or the potential for double-digit gains in equities. The double-digit returns, of course, may be negative double-digit to investors. It is basic physics that the higher something climbs, the further it has to fall. Both stocks and bonds are near priced near historic highs. This means they both have more potential downside than ever before.

Capturing Upside and Limiting Downside

Stocks have not exhibited any real weakness since late March 2020. The trend is still rapidly upward. People are putting more and more money in equities. The more money that goes in, the less money that can be used to help drive up prices later. And the more money that may run for cover later when an eventual selloff occurs.

Investors that expect an inevitable selloff will one day occur, but also that the market has more upside, could consider practicing a little defense. In today’s point-and-shoot world of stock trading both online and by phone app, many individuals don’t take the time to protect themselves from major losses. With the market continuously going up and quickly erasing any downward moves, investors have been rewarded for ignoring the fundamentals of risk management. The truth is, we don’t know when the big slide (or slow march) down will occur, but we do know we are closer to it than we were yesterday.

The two most basic methods for an individual to feel confident that their portfolio can still capture gains, without too much risk on the downside, are placing stop losses on their positions or buying puts. The stop losses cost the portfolio owner the erosion down to the Stop (sell price) only if hit. The cost of the Put is upfront and known even if it is never exercised which would be the case if the stock continued to perform well through the Put option’s expiration.

Using Stop Loss Orders

A stop-loss order gets you out of a stock you’re long when the price starts falling. If you’re short, a stop-loss buy order can be used. There are several types of stops you may use. A Hard Stop is when you set a fixed price that, if reached, triggers a market sell order. For example, you own “Company A” stock at $4.25; it is now trading at $7. Over the past few weeks, it has dropped to $6.50 several times but seems to have firm support there. To protect yourself if the stock should drop below that and keep going, you could set a hard stop a little below the $6.50 price. For example, If you set this stop loss at $6.30, an at-market sell order will be triggered when it hits $6.30.  In a world of commission-free trades, you may wish to quickly get back in at a lower price if it should drop considerably.

 

 

A Trailing Stop is a little different; it moves up with the stock price in a long position and down with the price in a short position. The order is spread to the price in terms of dollars or a percent difference. Using the example from above, if you set a trailing stop of 10% and Company A stock rises from $7.00 to $9.00, the trailing stop will move from the original $7 less $0.70 ($6.30) to $9 less $0.90 $8.10). The idea is more profit is captured when the stock does turn downward. A set dollar amount, rather than a percentage, can also be used for trailing stops.

Proponents of stop losses take comfort in their ability to protect the position from rapidly changing markets. Opponents could argue that both hard and trailing stops make temporary losses permanent. For an investor who is always monitoring their account and can trust their decision-making as moves unfold, they may feel a stop loss is not for them; they can stop losses on their own. Whether an investor uses them or not, once in a position, pre-planning various scenarios and actions you could take is critical to managing downside risk.  

At the end of the day, if you are going to have continued success as an investor, you have to be confident in your strategy. This means carrying through with your plan. The advantage of stop-loss orders is that they can help you stay on track and prevent your judgment from getting clouded with emotion.

Put Option

The S&P 500 declined in one out of every four years between 1926 and 2009. Then the “Great Financial Crisis” of 2008 cleared the way for years of stock market growth leading us to today’s heights. That is a very long barely interrupted growth trendline, historically. The most basic way for an investor to protect their upside gains is to take profits. One problem with this is what if the stock is still the best place for your money. After all, selling the stock means you have to do something else with the proceeds. When this is the case, locking in some of your gains, and holding the stock, can be done using the options market.

A common strategy is to buy a Put Option (a Put). This gives the holder the option of being able to sell stock at a certain price at a specific date in the future.  

For example, you own 100 shares of “Company B.” It has risen by 80% in a single year and now trades at $100. All the analysts covering the stock have price targets well in excess of $100, and the industry is experiencing a boom for the foreseeable future. But, who knows, some of these positives may already be built-in, and the bigger picture economy is questionable.  Or there could be a black swan event. To protect your profits, you could buy a Put on Company B with an expiration date six months into the future, and at a strike price (sale price) of $105, (slightly in the money). This option’s market value will fluctuate as you hold it with expectations, time to expiration,  and changes in the equities value. But, for the example, let’s say the option costs $600 ($6 per share). You now have the right (contractual ability) to sell 100 shares of Company B at $105.

If the stock drops to $90, the value of the Put will have risen significantly. At this point, you can sell the option for a profit to offset the decline in the stock price. Options do have expiration dates, at which time the contract for the counterparty to honor your ability to exercise the Put expires. It becomes an unused “insurance policy.”

Take-Away

With stocks and bonds trading at historic highs, being in either the equity or fixed income markets represents a greater potential for loss. There are tools and strategies which can protect you from extreme losses.

Getting completely out of any investment may not be the best plan. After all, everything has a cost, even doing nothing. Just think about the investors that stepped aside and went into cash during the first half of 2020, thinking, “it isn’t wise to be long during a pandemic.” They are likely worse off than if they had invested in a diversified mix of large and small-cap stocks. They didn’t get hurt by stepping aside, but they missed a huge run-up.

Investors that believe there is likely plenty of upside to a market index or particular stocks can still participate and capture much of it if it occurs. This, too, has a cost, but that cost serves as insurance against extreme losses.

Your broker can provide you with more detailed descriptions and various reasons when these strategies and other possible risk-limiting measures benefit your account. Each trading platform works differently, if you have questions you should contact a representative of your broker.

Paul Hoffman

Managing Editor, Channelchek

Suggested Reading:

Money Supply Drives Stock Market Performance

Can Small Investors Compete with Wall Street?

Seeking Alpha’s Paywall Causes Frustration

 

 

Stay up to date. Follow us:

           

Coeur Mining (CDE) 2020 Earnings Lower Than Expected Updating Estimates

Friday, February 19, 2021

Coeur Mining (CDE)
2020 Earnings Lower Than Expected: Updating Estimates

Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, rochester, wharf, and kensington. Its projects are located in the United States, Canada and Mexico, and North America.

Mark Reichman, Senior Research Analyst of Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Fourth quarter and full year 2020 financial results. Coeur reported adjusted fourth quarter and full year 2020 EPS of $0.08 and $0.24, respectively, compared to our estimates of $0.13 and $0.30. Variance to our estimates were largely due to lower revenue and higher income and mining taxes. We were looking for higher silver production and a modestly higher average realized price for gold. Coeur reported full year adjusted EBITDA of $263.4 million and generated free cash flow of $49.4 million. On a GAAP basis, fourth quarter and full year 2020 EPS were $0.05 and $0.11, respectively. Pre-adjusted 2020 EBITDA were $214.8 million.

    Guidance for 2021.  Coeur expects to produce between 322,500 and 367,500 ounces of gold and between 9.7 million and 12.2 million pounds of silver. This compares to 355,678 ounces of gold and 9.7 million pounds of silver produced in 2020. We have trimmed our 2021 EPS estimate to $0.55 from $0.57 and initiated a 2022 EPS estimate of $0.60. We forecast 2021 and 2022 EBITDA of $320.1 million and $340.0 …



This research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Great Lakes Dredge & Dock (GLDD) – A Softer End to Year But Positive Outlook Intact

Friday, February 19, 2021

Great Lakes Dredge & Dock (GLDD)
A Softer End to Year, But Positive Outlook Intact

Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. The company only’s operating segments is Dredging. Dredging involves the enhancement or preservation of navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand or rock. Its projects portfolio includes Coastal Restoration, Coastal Protection, Port expansion, and others.

Poe Fratt, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    4Q2020 results softer than expected due to higher costs and downtime/delays. Adjusted EBITDA of $29.4 million was below expectations of $33.5 million and EBITDA margin of 17.1% was below expectations of 17.7% due to higher S,G&A expenses, including severance and relocation costs, and higher maintenance expense caused by unexpected downtime. Good execution on most projects was offset by some weather delays in Florida.

    Fine tuning 2021 EBITDA estimate of $150.0 million which is down slightly from 2020 due to a 90 basis point drop in EBITDA margin to 19.7% mainly due to strong outperformance on several projects this year, especially in 1Q2020.  S,G&A expenses are expected to remain elevated in the 8.5% of revenue range due to costs to move to Texas. Admittedly, we are setting the bar at a reasonable level given …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Capstone Turbine (CPST) – Coverage Initiated on Capstone Turbine

Friday, February 19, 2021

Capstone Turbine (CPST)
Coverage Initiated on Capstone Turbine

Capstone Turbine Corp is the producer of low-emission microturbine systems.The company develops, manufactures, markets and services microturbine technology solutions for use in stationary distributed power generation applications. Capstone Turbine’s products include onboard generation for hybrid electric vehicles; conversion of oil field and biomass waste gases into electricity; combined heat, power, and chilling solutions; capacity addition; and standby power.

Michael Heim, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Capstone Turbine is a leading provider of on-site generation and thermal solutions. We believe that microturbines serve an important service for clients seeking to supplement or replace electric utility service. Growth has accelerated in recent quarters following a salesforce realignment. The long-term prospects for the company are also good. Increased environmental consciousness will push customers towards companies like Capstone that offer individualized client solutions that reduce emissions.

    Cost cutting should mean top-line growth goes right to the bottom line.  Capstone spent last year working to reduce costs with a goal of moving the company to positive cash flow generation. The company turned cash flow positive in the June quarter before reporting narrow losses in the September and December quarters, as it shifted its focus towards growing revenues. With a better-aligned cost …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Cannabis Fundamentals Not Hype Important to Investors

 


What Marijuana Investors Can Learn from the GameStop Trading Frenzy

 

Late January’s meteoric rise of GameStop’s shares made headlines, but what should be made of it? And what can we learn from it for marijuana?

What happened with GameStop is a short squeeze. The same thing happened to Tilray in 2018Volkswagen in 2008 and supermarket operator Piggly Wiggly in the 1920s.

While it is possible to profitably invest by selling whatever is rising at ever-higher prices for nonfundamental reasons, it is a tough zero-sum game where, by definition, someone must eventually lose.

Even the winner eventually loses as well when its trading counterparts run out of money or, as happened at Piggly Wiggly, when someone more powerful changes the rules of the game for their own benefit.

 

This article was originally published by MJBizDaily authored by Mike Regan who is the founder of MJResearchCo.com. Mike and fellow analyst Colin Ferrian are known for investment analysis and valuation of the cannabis industry. Reach them at mikeandcolin@mjresearchco.com.

 

Over the long term, MJResearchCo believes the highest and most reliable source of returns comes from the core function of capital markets – matching those who have more ideas than capital with those who have excess capital for a mutually beneficial deployment of capital at higher returns.

The focus should be on the fundamentals because that is what will drive true value creation over time in what we think is the most interesting secular growth theme of the next decade: legal cannabis.

But this does not mean we ignore price moves. You always need situational awareness to know when the game changes.

If you’re playing basketball with your friends, and 11 strangers in helmets and shoulder pads line up at half court, you need to realize you’re not playing basketball anymore and adjust your strategy.

If you continue to shoot three-pointers, you’re going to get tackled.

 

 

Fundamentals versus market mechanics: weighing versus voting

In Berkshire Hathaway’s 
1993 investor letter, Warren Buffett quoted his mentor, Ben Graham:

“In the short run, the market is a voting machine – reflecting a voter-registration test that requires only money, not intelligence or emotional stability – but in the long run, the market is a weighing machine.”

This is why opportunities to buy good companies at cheap prices exist. The “voting” of the market sells down something to below the value supported by fundamentals.

Over the short term, the value of a company is driven by whatever the last person wanted to pay for one share – and that can be for many reasons that have nothing to do with the fundamentals.

Unlike Buffett, we don’t bother judging the “intelligence” or “emotional stability” of the other side’s reasons.

For our purposes, we just want to understand why they’re offering those prices, even if we don’t agree with them.

Over the long term, the most solid support of a stock price is the fundamental profitability of the underlying business – the “weighing.”

If you can’t sell the stock (for example, because the public markets shut down or the company was private), the only return comes from the cash distributed to the equity owners in the form of dividends or share repurchases.

The best investors keep an eye on both the long-term fundamental “weighing” perspective and the near-term price moves from the “voting” perspective, and they buy good companies at low prices when the two diverge.

Companies weigh in with new capital issuance

Smart companies should have an idea of their own intrinsic worth and potential returns on existing and potential projects.

If the market bids up their stock, companies will issue new stock at high prices to fund those high-return projects.

In an ideal world, GameStop would sell as much new stock as it can after a tenfold increase in its market capitalization – which, ironically, would let them better fight their secular headwinds. But market dynamics probably prevent this.

Though not currently in a squeeze, cannabis stocks have traded up double digits (an average of 19% for U.S. operators and 55% on average for Canadian operators) after the Jan. 5 “blue wave” of Democrats’ wins in Georgia and Aphria’s better-than-expected earnings report.

With that investor enthusiasm, 18 companies have announced or issued $1.6 billion in new capital.

 

 

While some of this capital will be allocated into high-return new projects, some will be invested in disappointing projects – or even wasted on poor decisions and bad business models.

The key to determining that is the incremental return on invested capital (ROIC).

If the ROIC is high, the capital is used to expand high-return projects to the benefit of shareholders and the industry. Smart investors are happy about this.

Some projects could generate lower returns than expected, such as when excessive capital raises led to 
excessive cultivation capacity in Canada.

Ultimately, total supply was 2.5 times demand, which led to declines in cannabis prices that pressured margins and eventually reduced the returns on capital until new managers began to reduce excess capacity.

Or the capital might simply be spent on low-return luxuries for self-interested management at shareholders’ expense.

Determining which company is doing what kind of investments requires understanding the fundamentals of the business, the strategy, the uses of the new capital and the incentives and past behavior of management.

Over time, the only true value will be created by businesses providing desired services to paying repeat customers at good margins – not hoping to sell a never-profitable, low-ROIC business to a greater fool.

This article was originally published by MJBizDaily authored by Mike Regan who is the founder of MJResearchCo.com. Mike and fellow analyst Colin Ferrian are known for investment analysis and valuation of the cannabis industry. Reach them at mikeandcolin@mjresearchco.com.

 

 

Special Thanks to MJBizDaily
and
MJResearchCo.com for allowing us to share this article with our readers.

 

Stay up to date. Follow us:

           

Release – Kratos Defense & Security Solutions (KTOS) – Receives $55 Million C5ISR System Product Award


Kratos Receives $55 Million C5ISR System Product Award from National Security Customer

 

SAN DIEGO, Feb. 19, 2021 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a leading National Security Solutions provider, announced today that it has recently received an approximate $55 million, Single Award Indefinite Delivery, Indefinite Quantity (IDIQ) C5ISR product related contract from a National Security Customer. The contract has a period of performance of approximately five years. Kratos’ C5ISR Business is a leading provider of Command, Control, Communications, Computers, Combat Systems, Intelligence, Surveillance and Reconnaissance (C5ISR) related hardware, products, systems and solutions in support of unmanned drone, space and satellite communications, radar, missile defense, high power energy, strategic deterrence and other systems. Production and work under this new contract award will be performed primarily at a secure Kratos manufacturing facility. Due to customer related, competitive and other considerations, no additional information will be provided related to this contract award.

Tom Mills, President of Kratos C5ISR Division, said, “Our entire organization is focused on supporting our National Security Customer’s mission critical requirements, including in the unmanned aerial drone, strategic system and warfighter support areas, and we are proud to have received this recent contract award.”

Eric DeMarco, President and CEO of Kratos, said, “The entire Kratos Team continues to execute well, including as represented by this recent contract win. Over the past few years, we have been extremely focused on making the necessary investments to pursue and execute on large, new program opportunities and increasing our market share, and we believe that our recent strong book to bill ratio, total backlog and opportunity pipeline positions Kratos well for sustained organic growth.”

About Kratos Defense & Security Solutions

Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS) develops and fields transformative, affordable technology, platforms and systems for United States National Security related customers, allies and commercial enterprises. Kratos is changing the way breakthrough technology for these industries are rapidly brought to market through proven commercial and venture capital backed approaches, including proactive research and streamlined development processes. At Kratos, affordability is a technology, and we specialize in unmanned systems, satellite communications, cyber security/warfare, microwave electronics, missile defense, hypersonic systems, training, combat systems and next generation turbo jet and turbo fan engine development. For more information, go to www.KratosDefense.com.

Notice Regarding Forward-Looking Statements

Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of the management of Kratos and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Kratos undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Kratos believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Kratos in general, see the risk disclosures in the Annual Report on Form 10-K of Kratos for the year ended December 29, 2019, and in subsequent reports on Forms 10-Q and 8-K and other filings made with the SEC by Kratos.

Press Contact:
Yolanda White
858-812-7302 Direct

Investor Information:
877-934-4687

investor@kratosdefense.com

Source: Kratos Defense & Security Solutions, Inc.

QuickChek – February 19, 2021



Ayala Pharmaceuticals Announces $25 Million Strategic Financing

Ayala Pharmaceuticals, Inc. announced that it has entered into a definitive agreement for the sale of its equity securities in a private placement to institutional investors, including Redmile Group and SIO Capital Management.

Research, News & Market Data on Ayala Pharmaceuticals


Watch recent presentation from NobleCon17



EuroDry up 15% in early trading

EuroDry recently reported a better than expected adjusted 4Q2020 EBITDA. Noble Capital Markets Senior Analyst Poe Fratt increased his price target on EDRY on February 18.

Research, News & Market Data on EuroDry

Watch recent presentation from NobleCon17



Kratos Receives $55 Million C5ISR System Product Award

Kratos Defense & Security Solutions, a leading National Security Solutions provider, announced today that it has recently received an approximate $55 million, Single Award Indefinite Delivery, Indefinite Quantity (IDIQ) C5ISR product related contract from a National Security Customer.

Research, News & Market Data on Kratos Defense & Security Solutions



Citius Pharmaceuticals up 20% in early trading

Citius Pharmaceuticals (CTXR) recently announced a $76.5 million registered direct offering priced at-the-market. Closing is expected today.

News & Market Data on Citius Pharmaceuticals

Watch recent presentation from NobleCon17



Noble Capital Markets Initiates Research Coverge on Capstone Turbine

Noble Capital Markets Senior Research Analyst Michael Heim initiated research coverage on Capstone Turbine Corporation, a leading provider of on-site generation and thermal solutions today. Access the full report, with rating and price target here

Research, News & Market Data on Capstone Turbine

Watch recent presentation from NobleCon17

Stay up to date. Follow us:

           


Stay up to date. Follow us:

Release – Ayala Pharmaceuticals Announces $25 Million Strategic Financing


Ayala Pharmaceuticals Announces $25 Million Strategic Financing

 

Funding Extends Cash Runway through Multiple Expected Value Drivers Into 2023

Funds Expected to Support the Recently Announced Accelerated Development of AL102 for the Treatment of Desmoid Tumors into Pivotal Phase 2/3 Study

REHOVOT, Israel and WILMINGTON, Del., Feb. 19, 2021 (GLOBE NEWSWIRE) — Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, today announced that it has entered into a definitive agreement for the sale of its equity securities in a private placement to institutional investors, including Redmile Group and SIO Capital Management.

“We are very excited to have obtained additional funding enabling us to execute on our strategic priorities and support business growth from high quality US healthcare dedicated funds, which we also expect will extend our cash runway into 2023,” said Roni Mamluk, Ph.D., Chief Executive Officer of Ayala. “Ayala is well capitalized as we approach several key milestones planned for the remainder of 2021. We look forward to initiating our pivotal Phase 2/3 study of AL102 for the treatment of desmoid tumors in the first half of this year and presenting data from our Phase 2 study of AL101 for the treatment of recurrent/metastatic adenoid cystic carcinoma and triple negative breast cancer later this year.”

The agreement provides for the sale of an aggregate of 1,666,666 units at a price of $15 per unit. Each unit consists of one share of Ayala’s common stock and a warrant to purchase 0.35 of a share of common stock at an exercise price of $18.10 (the “Warrant”). One institutional investor has elected to receive pre-funded warrants to purchase common stock in lieu of its common stock. The Warrants are exercisable at any time during the period beginning on the closing date of the private placement and ending on the third anniversary of the closing. The gross proceeds from the sales of common stock are expected to be approximately $25 million, before deducting placement agent fees and offering expenses. The private placement is expected to close on or about February 23, 2021, subject to the satisfaction of customary closing conditions.

Jefferies LLC is acting as the exclusive placement agent for the private placement.

Based on Ayala’s current plans, it believes that its existing cash and cash equivalents and short-term restricted bank deposits, with the expected net proceeds from the private placement, will be sufficient to fund its operating expenses and capital expenditure requirements through multiple expected catalysts into 2023.

The securities to be sold in the private placement have not been registered under the Securities Act of 1933, as amended (Securities Act), or any state or other applicable jurisdiction’s securities laws, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state or other jurisdictions’ securities laws.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any offer, solicitation or sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

About Ayala Pharmaceuticals

Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. Ayala’s approach is focused on predicating, identifying and addressing tumorigenic drivers of cancer through a combination of its bioinformatics platform and next-generation sequencing to deliver targeted therapies to underserved patient populations. The company has two product candidates under development, AL101 and AL102, targeting the aberrant activation of the Notch pathway with gamma secretase inhibitors to treat a variety of tumors including Adenoid Cystic Carcinoma, Triple Negative Breast Cancer (TNBC), T-cell Acute Lymphoblastic Leukemia (T-ALL), Desmoid Tumors and Multiple Myeloma (MM) (in collaboration with Novartis). AL101 has received Fast Track Designation and Orphan Drug Designation from the U.S. FDA and is currently in a Phase 2 clinical trial for patients with ACC (ACCURACY) bearing Notch activating mutations and in a Phase 2 clinical trial for patients with TNBC (TENACITY) bearing Notch activating mutations and other gene rearrangements. AL102 is currently being advanced to a Phase 2/3 clinical trials for patients with desmoid tumors (RINGSIDE). For more information, visit www.ayalapharma.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including statements relating to the sufficiency of our cash, cash equivalents, restricted banks deposits and the net proceeds from the private placement to fund our operating expenses and capital expenditure requirements, the timing of clinical trials, the gross proceeds from the private placement, the closing of the private placement, and the use of proceeds from the private placement. These forward-looking statements are based on management’s current expectations. The words “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “estimate,” “believe,” “predict,” “potential” or “continue” or the negative of these terms or other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the following: the impact of the COVID-19 pandemic on our operations, including our preclinical studies and clinical trials, and the continuity of our business; we have incurred significant losses, are not currently profitable and may never become profitable; our need for additional funding; our expectations regarding our cash runway; our limited operating history and the prospects for our future viability; the lengthy, expensive, and uncertain process of clinical drug development, including potential delays in regulatory approval; our requirement to pay significant payments under product candidate licenses; the approach we are taking to discover and develop product candidates and whether it will lead to marketable products; the expense, time-consuming nature and uncertainty of clinical trials; enrollment and retention of patients; potential side effects of our product candidates; our ability to develop or to collaborate with others to develop appropriate diagnostic tests; protection of our proprietary technology and the confidentiality of our trade secrets; potential lawsuits for, or claims of, infringement of third-party intellectual property or challenges to the ownership of our intellectual property; risks associated with international operations; our ability to retain key personnel and to manage our growth; the potential volatility of our common stock; costs and resources of operating as a public company; unfavorable or no analyst research or reports; and securities class action litigation against us. These and other important factors discussed under the caption “Risk Factors” in our Quarterly Report on Form 10-Q for the three months ended September 30, 2020 filed with the U.S. Securities and Exchange Commission (SEC) on November 16, 2020 and our other filings with the SEC could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management’s estimates as of the date of this press release. New risk factors and uncertainties may emerge from time to time, and it is not possible to predict all risk factors and uncertainties. While we may elect to update such forward-looking statements at some point in the future, except as required by law, we disclaim any obligation to do so, even if subsequent events cause our views to change. Although we believe the expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such expectations will prove to be correct. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.

Contacts:
Investors:
Julie Seidel
Stern Investor Relations, Inc.
+1-212-362-1200
Julie.seidel@sternir.com

Ayala Pharmaceuticals:
+1-857-444-0553
info@ayalapharma.com

Source: Ayala Pharmaceuticals